| Literature DB >> 24454364 |
Abstract
Despite considerable efforts to tackle childhood obesity, it is recognized as one of the biggest health problems globally. Childhood obesity is a leading cause of many comorbid conditions such as metabolic syndrome and insulin resistance as well as type 2 diabetes. A strong body of evidence suggests that regular exercise without calorie restriction or weight loss is associated with reduced insulin resistance as well as improved insulin sensitivity in overweight and obese adults. However, despite the well-known benefits associated with regular exercise alone, the independent role of exercise training without calorie restriction on insulin resistance is still uncertain in youth. Some studies observed that both the aerobic and resistance type of exercise training without calorie restriction resulted in meaningful changes in insulin sensitivity, suggesting that exercise alone is an effective therapeutic strategy for reducing insulin resistance in overweight and obese youth. However, only few studies are available on the optimal dose of exercise training without calorie restriction or preferred exercise modality for reducing insulin resistance, which warrants further investigations in the pediatric population.Entities:
Year: 2013 PMID: 24454364 PMCID: PMC3876694 DOI: 10.1155/2013/402592
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Aerobic exercise and insulin resistance (nonrandomized controlled trials).
| References | Gender | Age | Treatment | BW | BMI | IS | Study | Protocol | ΔBW | ΔBMI | ΔIS | IS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nassis et al. [ | 19 girls | 9–15 | Exercise | 67.9 | 26.8 | 4.34 | 12 wk | 3 days/wk, 40 min/day | 0.4 | −0.1 | 1.1 | HOMA-IR |
|
| ||||||||||||
| Caranti et al. [ | 37 boys | 15–19 | Exercise | 102.8 | 36.2 | 4.8 | 1 yr | Exercise combined with nutrition, psychological, clinical therapy | −10.5* | −4.1* | −33.3* | HOMA-IR |
|
| ||||||||||||
| Monzavi et al. [ | 60 boys | 8–16 | Exercise | 78.2 | 33.7 | 5.52 | 12 wk | Lifestyle intervention program | 0.1 | −0.5* | −32.6 | HOMA-IR |
|
| ||||||||||||
| Kelishadi et al. [ | 19 boys | 12–18 | Exercise | 57.1 | 25.3 | 5.4 | 6 wk | 3 days/wk, 60 min/day | −2.4* | −1.2* | −22.2* | HOMA-IR |
|
| ||||||||||||
| Van der Heijden et al. [ | 17 boys | 15.1 | Obese exercise | 91.7 | 33.7 | 4.9 | 12 wk | 2 days/wk, 30 min/day | −0.5†
| −0.4†
| −16.3∗†
| HOMA-IR |
BMI: body mass index; BW: body weight; HOMA-IR: homeostasis model assessment of insulin resistance; IS: insulin sensitivity; Δ: Change score.
*Significantly different from baseline within each group (P < 0.05).
†Significantly different from controls or other groups (P < 0.05).
Aerobic exercise and insulin resistance (randomized controlled trials).
| References | Gender | Age | Treatment | BW | BMI | IS | Study | Protocol | ΔBW | ΔBMI | ΔIS | IS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kelly et al. [ | 9 boys | 11.0 | Control | 73.5 | 30.5 | 6.0 | 8 wk | 4 times/wk, 30–50 min/session | 0.8 | −0.1 | −2.8 | 2 h Glucose (OGTT) |
|
| ||||||||||||
| Meyer et al. [ | 47 boys | 12–16 | Control | NA | 31.0 | 4.4 | 6 mo | 3 days/wk, 60–90 min/day | NA | 0.3 | 11.0 | HOMA-IR |
|
| ||||||||||||
| Kim et al. [ | 26 boys | 17.0 | Control | 90.4 | 29.4 | 2.9 | 6 wk | 5 days/wk, 40 min/day | 0.0 | −0.3 | −18.2 | HOMA-IR |
|
| ||||||||||||
| Savoye et al. [ | 68 boys | 8–16 | Control | 91.2 | 36.2 | 5.2 | 1 yr | Exercise & behavior modification. | 6 mo/1 yr | 6 mo/1 yr | 6 mo/1 yr | HOMA-IR |
|
| ||||||||||||
| Lee et al. [ | 45 boys | 12–18 | Control | 100.0 | 33.9 | 2.7 | 3 mo | 3 days/wk, 60 min/session | 2.6* | 0.3 | −3.7 | Euglycemic clamp |
|
| ||||||||||||
| Davis et al. [ | 94 boys | 7–11 | Control | NA | 26.3 | 2.5 | 10–15 wk | 5 days/wk, HR > 150 bpm | NA | NA | Adjusted mean diff. 0.11 (high versus low) | Matsuda index of insulin sensitivity |
BMI: body mass index; BW: body weight; HOMA-IR: homeostasis model assessment of insulin resistance; IS: insulin sensitivity; OGTT: oral glucose tolerance test; Δ: Change score.
*Significantly different from baseline within each group (P < 0.05).
†Significantly different from controls or other groups (P < 0.05).
Resistance or combined exercise and insulin resistance (nonrandomized controlled trials).
| References | Gender | Age | Treatment | BW | BMI | IS | Study | Protocol | ΔBW | ΔBMI | ΔIS | IS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treuth et al. [ | 22 girls | 7–10 | Control (lean) | 29.1 | NA | NA | 5 mo | 3 days/wk, 50% of 1RM | 2.9* | NA | NA | Insulin AUC (OGTT) |
|
| ||||||||||||
| Bell et al. [ | 8 boys | 12.7 | Exercise | 80.6 | 31.6 | 8.2 | 8 wk | 3 days/wk, 60 min/session | 0.6 | −0.4 | 22.2* | Euglycemic clamp |
|
| ||||||||||||
| Van der Heijden et al. [ | 6 boys | 15.5 | Exercise | 97.0 | 35.3 | 3.0 | 12 wk | 2 times/wk, 60 min/session | 2.6* | 0.8* | 24.0* | Hepatic insulin sensitivity index |
BMI: body mass index; BW: body weight; HOMA-IR: homeostasis model assessment of insulin resistance; IS: insulin sensitivity; OGTT: oral glucose tolerance test; RM: repetition maximum; Δ: Change score.
*Significantly different from baseline within each group (P < 0.05).
†Significantly different from controls or other groups (P < 0.05).
Resistance or combined exercise and insulin resistance (randomized controlled trials).
| References | Gender | Age | Treatment | BW | BMI | IS | Study | Protocol | ΔBW | ΔBMI | ΔIS | IS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shaibi et al. [ | 22 boys | 15.6 | Control | 98.3†
| 34.6 | 1.7 | 16 wk | 2 days/wk, <1 h/session | 2.1 | 0.4 | 5.9 | FSIVGTT |
|
| ||||||||||||
| Chang et al. [ | 36 boys | 12–14 | Control | 71.3 | 27.1 | 7.5 | 1 yr | 2–5 times/wk, 60–90 min/session | 9 mo/1 yr | 9 mo/1 yr | 9 mo/1 yr | HOMA-IR |
|
| ||||||||||||
| Benson et al. [ | 46 boys | 10–15 | Control | 51.7 | 22.1 | 1.1 | 8 wk | 2 days/wk, 2 sets, 8 reps | 2.0 | 0.4 | 0.2 (log) | HOMA-IR |
|
| ||||||||||||
| Davis et al. [ | 28 boys | 14–18 | Control | 93.0 | 33.7 | 1.8 | 16 wk | 2 days/wk, <1 h/session | 0.6 | 0.2 | 5.6 | FSIVGTT |
|
| ||||||||||||
| Davis et al. [ | 44 youth | 14–18 | Control | 94.4 | 36.4 | 4.9 | 16 wk | 2 days/week, 60–90 min/session | NA | NA | −4.0 | HOMA-IR |
|
| ||||||||||||
| Lee et al. [ | 45 boys | 12–18 | Control | 100.0 | 33.9 | 2.7 | 3 mo | 3 days/wk, 60 min/session | 2.6* | 0.3 | −3.7 | Euglycemic clamp |
BMI: body mass index; BW: body weight; EDU: education; FSIVGTT: frequently sampled intravenous glucose tolerance test; HOMA-IR: homeostasis model assessment of insulin resistance; IS: insulin sensitivity; OGTT: oral glucose tolerance test; RM: repetition maximum; Δ: change score.
*Significantly different from baseline within each group (P < 0.05).
†Significantly different from controls or other groups (P < 0.05).